Fred Alger Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-71,569
| Closed | -$2.88M | – | 478 |
|
|
2024
Q4 | $2.88M | Sell |
71,569
-417,300
| -85% | -$16.8M | 0.01% | 298 |
|
|
2024
Q3 | $31M | Sell |
488,869
-78,415
| -14% | -$4.96M | 0.15% | 105 |
|
|
2024
Q2 | $30.1M | Buy |
567,284
+100,068
| +21% | +$5.3M | 0.15% | 98 |
|
|
2024
Q1 | $38.3M | Buy |
+467,216
| New | +$38.3M | 0.19% | 100 |
|
|
2023
Q2 | – | Sell |
-26,597
| Closed | -$443K | – | 576 |
|
|
2023
Q1 | $443K | Buy |
+26,597
| New | +$443K | ﹤0.01% | 408 |
|
|
2019
Q2 | – | Sell |
-68,000
| Closed | -$676K | – | 563 |
|
|
2019
Q1 | $676K | Buy |
68,000
+40,000
| +143% | +$398K | ﹤0.01% | 356 |
|
|
2018
Q4 | $214K | Sell |
28,000
-7,000
| -20% | -$53.5K | ﹤0.01% | 379 |
|
|
2018
Q3 | $610K | Buy |
+35,000
| New | +$610K | ﹤0.01% | 348 |
|